Athenex Announces FDA Allowance of IND Application for TCRT-ESO-A2, a TCR-T Cell Therapy
BUFFALO, N.Y., Sept. 23, 2020 (GLOBE NEWSWIRE) — Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, […]
Lantronix Announces Ultra-Compact Open-Q 865XR System on Module (SOM) to Power Internet of Things Solutions
IRVINE, Calif., Sept. 23, 2020 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX) a global provider of Software as a Service […]
AC Immune Reports Top Line Results from TAURIEL Phase 2 Trial Evaluating Semorinemab in Early Alzheimer’s Disease
Genentech disclosed that the anti-Tau antibody did not meet the co-primary efficacy endpoint or two secondary endpoints in the TAURIEL […]
Akoustis Receives XBAW RF Filter Design Win and Order from New 5G Small Cell Infrastructure Customer
– Band n79 Filter for New Small Cell Product Aimed at 5G Network Operators –– Akoustis Expects Production Ramp in […]
Hamilton Lane Names Paul Yett as Director of ESG & Sustainability
BALA CYNWYD, Pa., Sept. 23, 2020 (GLOBE NEWSWIRE) — Leading private markets asset management firm Hamilton Lane (NASDAQ: HLNE) today […]
First Patient Randomized in the Phase 3 DISSOLVE Clinical Program of SEL-212 for Chronic Refractory Gout
STOCKHOLM, Sweden and WATERTOWN, Mass., Sept. 23, 2020 (GLOBE NEWSWIRE) — Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) and Selecta […]
36Kr Holdings Inc. Announces Strategic Collaboration with Youku to Enhance Content Commercialization
BEIJING, Sept. 23, 2020 (GLOBE NEWSWIRE) — 36Kr Holdings Inc. (“36Kr” or the “Company”) (NASDAQ: KRKR), a prominent brand and […]
Morphic Therapeutic Announces First Healthy Volunteers Dosed in Phase 1 Clinical Trial of MORF-057
First orally available integrin inhibitor from MInT Platform to enter the clinicMORF-057, inhibitor of α4β7integrin, in development to treat inflammatory […]
MediciNova Announces that its Intranasal COVID-19 Vaccine Successfully Induced Systemic IgG and Mucosal IgA Neutralizing Antibodies Against SARS-CoV-2 in Mice using BC-PIV Vector Technology
LA JOLLA, Calif., Sept. 23, 2020 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market […]
INmune Bio, Inc. to Host Key Opinion Leader Webinar on Treatment Resistant Depression on Tuesday, September 29
LA JOLLA, Calif., Sept. 23, 2020 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused […]
